BLOGS

World’s First Lung Cancer Vaccine Enters Global TrialsThe world’s first mRNA-based lung cancer vaccine, BNT116, has officially entered Phase I clinical trials across seven countries, marking a major milestone in cancer therapeutics. Developed by BioNTech, the vaccine is being tested at 34 research sites in the UK, US, Germany, Hungary, Poland, Spain, and Turkey lcfamerica.org+15theguardian.com+15insideprecisionmedicine.com+15. This study represents a significant step forward in applying mRNA technology—proven effective in COVID‑19 vaccines—to combat non-small cell lung cancer (NSCLC), which remains the leading cause of cancer-related deaths worldwide.

Trial Design and ParticipantsApproximately 130 patients diagnosed with NSCLC—ranging from early-stage before surgery to advanced…

Read More

A first-of-its-kind treatment to slow the progression of early Alzheimer’s has recently been approved for use in Australia. The Therapeutic Goods Administration (TGA) has registered Kisunla (donanemab), a monthly intravenous infusion designed for adults in the early stages of Alzheimer’s who test positive for amyloid plaques in the brain fda.gov+159news.com.au+15brightfocus.org+15. This marks a significant milestone—the first new disease-modifying therapy for Alzheimer’s in Australia in 25 years heraldsun.com.au+1news.com.au+1.

Donanemab belongs to a class of antibody treatments targeting amyloid-β, the sticky protein clumps believed…

Read More

New COVID Variant NB.1.8.1 Detected via U.S. Airport ScreeningsAirport screening programs in the United States have identified the emerging Omicron subvariant NB.1.8.1—also known as “Nimbus”—in travelers arriving at destinations in California, Washington, Virginia, and New York pbs.org+15wwnytv.com+15m.economictimes.com+15. First flagged in late March and early April among international arrivals, the variant has since been reported in over 20 countries and is currently under close monitoring by global health agencies nypost.com+1economictimes.indiatimes.com+1.

Global Spread and Public Health AssessmentNB.1.8.1 has been linked to recent case surges, particularly across…

Read More

Babesiosis is a rare but increasingly important tick‑borne disease caused by the protozoan Babesia microti, which invades red blood cells and can cause flu‑like symptoms—fever, body aches, chills, and fatigue. While often mild, it can become severe or life‑threatening in the elderly, splenectomized, or immunocompromised. Historically, babesiosis has been endemic to the Northeast and Upper Midwest of the U.S., transmitted primarily by the black‑legged tick (Ixodes scapularis) cdc.gov+15en.wikipedia.org+15bioengineer.org+15self.com+4smithsonianmag.com+4smnewsnet.com+4.

A major new study spanning 2009–2024, published in the Journal of Medical Entomology, reveals that…

Read More

Urinary tract infections (UTIs) are among the most common infections, particularly for women, who experience an estimated 15 million UTIs annually in the U.S. alone yahoo.com+6bloomberg.com+6ncbi.nlm.nih.gov+6. To ease the burning, urgency, and discomfort while waiting for antibiotics, many reach for OTC remedies like phenazopyridine—found in brands such as Azo and Uristat—which numbs urinary tract tissue for relief dentistryiq.com+7en.wikipedia.org+7nypost.com+7.

However, phenazopyridine has not undergone full FDA approval; it was “grandfathered” in before modern safety…

Read More

A woman was urgently taken to the emergency room after experiencing a severe headache that worsened rapidly. Alongside the headache, she showed other concerning symptoms such as fever, neck stiffness, and sensitivity to light. These signs prompted the medical team to conduct a thorough examination to determine the cause of her condition. Given the severity of her symptoms, the doctors suspected meningitis, an inflammation of the membranes surrounding the brain and spinal cord.

After conducting diagnostic tests, including a lumbar puncture to analyze cerebrospinal fluid, the doctors confirmed…

Read More